Hing-Kin Chan
Corporate Officer/Principal chez Royal Pharmaceutical Society of Great Britain
Profil
Hing-Kin Chan is a professional with current jobs at the Royal Pharmaceutical Society of Great Britain and Gerson Lehrman Group Councils as a Member and Member-Healthcare Council respectively.
Postes actifs de Hing-Kin Chan
| Sociétés | Poste | Début |
|---|---|---|
Royal Pharmaceutical Society of Great Britain
 Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Corporate Officer/Principal | 10/08/2011 |
| Gerson Lehrman Group Councils | Corporate Officer/Principal | 11/08/2011 |
Anciens postes connus de Hing-Kin Chan
| Sociétés | Poste | Fin |
|---|---|---|
| MERRION PHARMACEUTICALS PLC | Corporate Officer/Principal | - |
Riboxx GmbH
 Riboxx GmbH Medical/Nursing ServicesHealth Services Riboxx GmbH operates as a biotechnology company. Its expertise is to design, engineer and manufacture ribonucleic acid (RNA). The company was founded by Jacques Rohayem on May 7, 2009 and is headquartered in Dresden, Germany. | Corporate Officer/Principal | - |
Colorcon, Inc.
 Colorcon, Inc. Pharmaceuticals: MajorHealth Technology Colorcon, Inc. develops and supplies pharmaceutical film coatings and formulation. It offers film coating systems, modified release technologies and functional excipients, as well as tablet design services which enable pharmaceutical companies to distinguish their tablets through color, shape, high-definition imaging, special coatings, flavors and product security identifiers. The company was founded in 1961 and is headquartered in Harleysville, PA. | Corporate Officer/Principal | - |
IDEA AG
 IDEA AG Pharmaceuticals: MajorHealth Technology IDEA AG develops pain therapeutics and biopharmaceutical drugs. The firm develops and commercializes non-invasive therapeutic drugs and the targeted pain therapeutics for arthritic and osteoporosis-related inflammation, chronic pain and diseases. Its technology platform is based on proprietary carriers applied on skin and engineered to diminish side effects and increase drug potency. The company founded by Gregor Cevc in 1993 and is headquartered in Munich, Germany. | Corporate Officer/Principal | - |
Eurand SpA
 Eurand SpA Pharmaceuticals: MajorHealth Technology Eurand SpA is a specialty pharmaceutical company that develops, manufactures, and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. With integrated manufacturing and R&D facilities in the U.S. and Europe, the company has partnered with pharmaceutical companies licensing its four primary technology platforms: Customized Drug Release, Bioavailability Enhancement, Taste Masking or Oral Disintegrating Tablets, and Drug Conjugation. The company is headquartered in Pessano con Bornago, Italy. | Corporate Officer/Principal | - |
Formation de Hing-Kin Chan
| University of London | Undergraduate Degree |
| University of Geneva | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DBV TECHNOLOGIES | Health Technology |
| Entreprise privées | 8 |
|---|---|
ProBioGen AG
 ProBioGen AG Miscellaneous Commercial ServicesCommercial Services ProBioGen AG operates as a contract development and manufacturing organization. It specializes in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. The firm offers services such as cell line development, process development, manufacturing programs, physio-chemical analyses, and cell-based assays. The company was founded by Uwe Marx on June 13, 1994 and is headquartered in Berlin, Germany. | Commercial Services |
Eurand SpA
Eurand SpA Pharmaceuticals: MajorHealth Technology Eurand SpA is a specialty pharmaceutical company that develops, manufactures, and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. With integrated manufacturing and R&D facilities in the U.S. and Europe, the company has partnered with pharmaceutical companies licensing its four primary technology platforms: Customized Drug Release, Bioavailability Enhancement, Taste Masking or Oral Disintegrating Tablets, and Drug Conjugation. The company is headquartered in Pessano con Bornago, Italy. | Health Technology |
IDEA AG
IDEA AG Pharmaceuticals: MajorHealth Technology IDEA AG develops pain therapeutics and biopharmaceutical drugs. The firm develops and commercializes non-invasive therapeutic drugs and the targeted pain therapeutics for arthritic and osteoporosis-related inflammation, chronic pain and diseases. Its technology platform is based on proprietary carriers applied on skin and engineered to diminish side effects and increase drug potency. The company founded by Gregor Cevc in 1993 and is headquartered in Munich, Germany. | Health Technology |
Colorcon, Inc.
Colorcon, Inc. Pharmaceuticals: MajorHealth Technology Colorcon, Inc. develops and supplies pharmaceutical film coatings and formulation. It offers film coating systems, modified release technologies and functional excipients, as well as tablet design services which enable pharmaceutical companies to distinguish their tablets through color, shape, high-definition imaging, special coatings, flavors and product security identifiers. The company was founded in 1961 and is headquartered in Harleysville, PA. | Health Technology |
Merrion Pharmaceuticals Plc
 Merrion Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Merrion Pharmaceuticals Plc engages in the development of oral forms of drugs which have suboptimal absorption. It also invests in companies focusing in the healthcare sector. The company was founded by Michael Mary Donnelly in December 2003 and is headquartered in Dublin, Ireland. | Health Technology |
Royal Pharmaceutical Society of Great Britain
Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Commercial Services |
| Gerson Lehrman Group Councils | |
Riboxx GmbH
Riboxx GmbH Medical/Nursing ServicesHealth Services Riboxx GmbH operates as a biotechnology company. Its expertise is to design, engineer and manufacture ribonucleic acid (RNA). The company was founded by Jacques Rohayem on May 7, 2009 and is headquartered in Dresden, Germany. | Health Services |
